Rockefeller Capital Management
CLPT icon

Rockefeller Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Rockefeller Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.4K Buy
1,800
+300
+20% +$3.79K ﹤0.01% 3790
2025
Q4 		$20.5K Buy
1,500
+170
+13% +$3.15K ﹤0.01% 3507
2025
Q3 		$29K Buy
+1,330
New +$15.7K ﹤0.01% 3171

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Rockefeller Capital Management's CLPT Position: Q1 2026 in Review

Rockefeller Capital Management increased its ClearPoint Neuro (CLPT) stake by 20% in Q1 2026, buying an estimated $3.79K and bringing the position to 1,800 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3790.

Rockefeller Capital Management first reported a position in CLPT in Q3 2025 and has held it in 3 quarters since. The position peaked at $29K in Q3 2025. 118 funds tracked by Wall St. Rank hold CLPT as of Q1 2026.

  • Rockefeller Capital Management held 1,800 shares of ClearPoint Neuro worth $16.4K as of Q1 2026.
  • Rockefeller Capital Management bought 300 ClearPoint Neuro shares in Q1 2026, an estimated $3.79K.
  • ClearPoint Neuro made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #3790 holding.
  • Rockefeller Capital Management first reported a position in ClearPoint Neuro in Q3 2025 and has held it in 3 quarters since.
  • Rockefeller Capital Management's ClearPoint Neuro position peaked at $29K in Q3 2025.
  • 118 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.